Vendor-neutral advantage Cerno Bioscience offers a vendor-neutral mass spectrometry software platform that works across all instruments, presenting a direct cross-sell opportunity to labs with diverse MS setups and a need to unify workflows.

Mass spec accuracy Recent focus on correcting MS signals to improve accuracy for small and large molecules creates a compelling value proposition for customers seeking higher confidence in complex mixture analyses, driving upsell to premium software features.

ASMS exposure Active participation in major conferences like ASMS provides frequent networking and demonstration opportunities to showcase breakthroughs, enabling targeted follow-ups with attendees from labs evaluating upgrades or new platforms.

Small team agility With a small headcount, Cerno can prioritize high-touch pilots and rapid onboarding, appealing to research groups and mid-sized facilities looking for flexible, scalable software solutions without large enterprise commitments.

Analytics expansion Past launches for large-molecule analysis and GC/ID enhancements hint at opportunities to cross-sell analytics modules, training services, and instrument-agnostic workflows to expand revenue beyond core software.